Governance Classic Home
Caplin Point Laboratories LtdPharmaceuticalsINE475E01026Consolidated₹2748.60+152.00 (+5.85%)Jun-26
Valuation
Market Cap₹20.89K Cr
TTM PE31.40x
Forward PE30.67x
PEG8.35
Book Value₹471.82
P/B5.83x
TTM EPS₹87.53
Fwd EPS₹89.61
TTM Revenue₹2.29K Cr
TTM PAT₹678.06 Cr
TTM EBITDA₹796.58 Cr
TTM EBIT₹718.48 Cr
Last Qtr PAT₹179.09 Cr
Last Qtr EBITDA₹213.48 Cr
Last Qtr EBIT₹191.86 Cr
Profitability
ROE18.91%
ROCE23.53%
TTM NPM29.64%
TTM EBITDA %34.83%
Curr OPM27.81%
Last OPM27.51%
Curr NPM—
Last NPM—
Curr EPS₹23.27
Last EPS₹22.38
Balance sheet
Equity₹15.20 Cr
Reserve₹3.57K Cr
Total Debt₹2.37 Cr
D/E0.00x
Interest %0.10%
Curr Interest₹0.18 Cr
Price / range
Close₹2748.60
vs 52W High—
vs 52W Low—
MA50—
MA200—
Returns
1D+5.85%
1W-0.23%
1M+8.65%
3M+16.50%
6M+66.66%
1Y+18.48%
2Y+39.76%
3Y+163.86%
5Y+215.59%
Diwali+52.89%
Sector peers — Pharmaceuticals
CompanyCloseMkt CapTTM P/EROE
SUNPHARMA1837.30₹4.41L Cr36.4514.50%
DIVISLAB9375.00₹2.49L Cr85.0617.45%
TORNTPHARM4840.00₹1.84L Cr77.3225.70%
ZYDUSLIFE1160.00₹1.16L Cr25.8516.94%
CIPLA1394.50₹1.13L Cr33.419.75%
LAURUSLABS1954.00₹1.06L Cr96.4520.58%
AUROPHARMA1734.00₹99.77K Cr27.099.79%
DRREDDY1185.00₹98.91K Cr30.638.40%

Financial Results

Quarterly and yearly P&L · YoY % on Revenue, Total Income, Expenditure, EBITDA, EBIT, PBT, Net Profit and EPS

Standalone

16 lines · 6 periods
MetricJun-26Mar-26Dec-25Sep-25Jun-25FY25-26
Revenue202.95+11.2%191.36189.22175.18182.57738.33
Other Income62.7961.0831.7359.2232.03195.37
Total Income265.74+23.8%252.44220.95234.40214.60933.70
Interest0.050.050.070.050.040.20
Expenditure-115.15-12.7%-114.72-103.94-105.40-102.14-426.18
PBDT000000
EBITDA94.41+9.0%83.5991.7275.8586.61337.78
Depreciation-6.56-6.90-6.37-6.02-6.14-25.43
EBIT87.85+9.2%76.6985.3569.8380.47312.35
PBT150.59+33.9%137.72117.01129112.46507.52
Tax-30.21-28.22-29.73-26.41-26.57-110.94
Equity15.2015.2015.20015.2015.20
OPM56.6754.5652.9673.6452.4054.36
Net Profit120.38+40.2%109.5087.28102.5985.89396.58
NPM45.3043.3839.5058.5640.0242.47
EPS15.84+40.2%15.8911.4913.5011.3052.17

Yearly results

Last 6 financial years · YoY % vs previous FY

Yearly

17 lines · 6 years
MetricFY 25-26FY 24-25FY 23-24FY 22-23FY 21-22FY 20-21
Revenue738.33-1.9%752.41+20.4%625.09+18.3%528.61+0.1%528.06+9.4%482.68
Other Income195.37134.59105.849956.5518.62
Total Income933.70+5.3%887+21.4%730.93+16.5%627.61+7.4%584.61+16.6%501.30
Expenditure-426.18+4.3%-445.33-21.9%-365.19-9.2%-334.460.0%-334.30-14.7%-291.36
Interest-0.20-0.12-0.10-0.12-0.09-0.17
PBDT000000
EBITDA337.78+1.8%331.97+15.6%287.08+30.5%219.92+0.1%219.62+2.7%213.93
Depreciation-25.43-24.77-27.08-25.65-25.77-22.44
EBIT312.35+1.7%307.20+18.2%260+33.8%194.27+0.2%193.85+1.2%191.49
PBT507.52+14.9%441.67+20.8%365.74+24.8%293.15+17.1%250.31+19.2%209.94
Tax-110.94-102.18-82.03-58.89-62.44-53.71
Equity15.2015.200000
OPM (%)54.3649.7950.0047.0043.0042.00
Net Profit396.58+16.8%339.49+19.7%283.71+21.1%234.26+24.7%187.87+20.3%156.23
NPM (%)42.4738.2739.0037.0032.0031.00
EPS (Rs)52.17+16.8%44.67+19.6%37.36+20.9%30.89+24.5%24.82+20.2%20.65
CEPS52.0244.4737.1830.6224.6020.45

Consolidated

16 lines · 6 periods
MetricJun-26Mar-26Dec-25Sep-25Jun-25FY25-26
Revenue610.36+19.6%600.16542.77534.04510.222,187.19
Other Income33.5528.3633.6830.3723.14115.54
Total Income643.91+20.7%628.52576.45564.41533.362,302.73
Interest0.180.360.180.160.180.87
Expenditure-418.68-20.0%-415.08-372.54-363.43-348.93-1,499.98
PBDT000000
EBITDA213.48+20.1%204.24189.69189.17177.76760.85
Depreciation-21.62-18.80-19.28-18.40-16.29-72.77
EBIT191.86+18.8%185.44170.41170.77161.47688.08
PBT225.23+22.1%213.44203.91200.98184.43802.79
Tax-46.13-40.56-38.03-40.77-33.70-153.06
Equity15.2015.200015.2015.20
OPM34.9833.9635.3735.6134.5834.86
Net Profit179.09+18.8%172.88165.86160.23150.76649.73
NPM27.8127.5128.7728.3928.2728.22
EPS23.27+15.8%22.3821.5620.3220.1084.36

Yearly results

Last 6 financial years · YoY % vs previous FY

Yearly

17 lines · 6 years
MetricFY 25-26FY 24-25FY 23-24FY 22-23FY 21-22FY 20-21
Revenue2,187.19+12.9%1,937.47+14.4%1,694.10+15.5%1,466.73+15.5%1,269.41+19.6%1,061.29
Other Income115.5496.4366.9455.9838.7523.54
Total Income2,302.73+13.2%2,033.90+15.5%1,761.04+15.7%1,522.71+16.4%1,308.16+20.6%1,084.83
Expenditure-1,499.98-10.5%-1,357.11-13.4%-1,196.88-11.7%-1,071.44-16.2%-922.34-19.6%-771.21
Interest-0.87-0.61-0.78-0.78-0.70-1.59
PBDT000000
EBITDA760.85+17.6%646.93+17.3%551.44+25.0%441.06+11.8%394.67+20.1%328.64
Depreciation-72.77-65.96-53.44-44.99-46.90-36.97
EBIT688.08+18.4%580.97+16.7%498+25.7%396.07+13.9%347.77+19.2%291.67
PBT802.79+18.6%676.79+19.9%564.43+25.1%451.35+17.0%385.82+23.0%313.62
Tax-153.06-135.69-103.01-74.36-77.37-62.18
Equity15.2015.200000
OPM (%)34.8633.2832.0529.6429.4928.91
Net Profit649.73+20.1%541.09+17.3%461.42+22.4%376.99+22.2%308.45+22.7%251.44
NPM (%)28.2226.6026.2024.7623.5823.18
EPS (Rs)84.36+19.5%70.57+17.2%60.19+21.3%49.62+25.3%39.61+23.7%32.03
CEPS84.1170.2559.9049.1839.2631.71

Corporate Actions

Dividends, bonus issues, and stock splits

Dividend

25
YearTypeAmountEx-Date
2026Final Dividend418 Sep 2026
2027Interim Dividend429 May 2026
2025Final Dividend312 Sep 2025
2026Interim Dividend330 May 2025
2024Final Dividend2.523 Sep 2024
2025Interim Dividend2.531 May 2024
2023Final Dividend2.514 Sep 2023
2024Interim Dividend209 Jun 2023
2022Final Dividend221 Sep 2022
2023Interim Dividend223 May 2022
2021Final Dividend1.520 Sep 2021
2022Interim Dividend1.518 May 2021
2020Final Dividend0.421 Sep 2020
2020Interim Dividend2.112 Mar 2020
2019Final Dividend2.204 Sep 2019
2018Final Dividend218 Sep 2018
2017Final Dividend1.507 Sep 2017
2016Final Dividend3.501 Sep 2016
2016Interim Dividend2.515 Feb 2016
2015Final Dividend529 Oct 2015
2014Final Dividend411 Dec 2014
2013Final Dividend2.519 Dec 2013
2012Final Dividend211 Dec 2012
2011Final Dividend1.512 Dec 2011
2010Final Dividend109 Dec 2010

Bonus

0

No bonus history.

Split

1
YearRatioEx-Date
2016Rs.10/- to Rs.2/-19 Oct 2016
Loading company dashboard...
Fetching ratios, charts, and peers